Avanir制药(AVNR)

16.96 0.00 0.0%

今开:0.0昨收:16.96
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:3.286147603E9

Avanir制药的最新讨论

“芯片独角兽”澜起科技的做空往事

股市动态分析周刊2019-07-18 17:04

作者:于辰琪
来源:阿尔法工场
登陆科创板前夕,“芯片独角兽”澜起科技,再因当年在美国市场被做空的往事,以及管理层天价年薪问题,被推至聚光灯下。
有业内人士撰文称,澜起科技人均工资143万元,董事长总经理两个人一年工资3550万元,曾在纳斯达克遭遇做空,后被纳斯达克警示,最...查看全文

徐洪锋2019-07-18 08:42

【“芯片独角兽”澜起科技的做空往事】
原创: 于辰琪 阿尔法工场
作者为阿尔法工场研究员
导语:做空疑点已经不复存在,但头顶的乌云仍未散尽。
登陆科创板前夕,“芯片独角兽”澜起科技,再因当年在美国市场被做空的往事,以及管理层天价年薪问题,被推至聚光灯下。
(点击...查看全文

ffwander2014-12-02 22:39

$Avanir Pharmaceuticals(AVNR)$ 晕死,上周下车的,转arwr亏惨了查看全文

王伟CFA美股MCORLEO2014-12-02 22:23

$Avanir Pharmaceuticals(AVNR)$ 曾经的潜在客户啊 差点就成了查看全文

an小安2014-12-02 22:21

$Avanir Pharmaceuticals(AVNR)$大冢制药买了avanir,35亿美元查看全文

ffwander2014-11-04 20:43

$Avanir Pharmaceuticals(AVNR)$ Nov 26: FDA approval decision: Avanir Pharma (AVNR) AVP-825 for migraine.查看全文

臻颓2014-10-31 13:40

$Avanir Pharmaceuticals(AVNR)$ 终于突破了查看全文

臻颓2014-09-24 19:50

$Avanir Pharmaceuticals(AVNR)$盘前终于涨了[牛]查看全文

1 2 3

Avanir制药的公告

内部交易: 2012-03-06,副总裁, Finance,OCAMPO CHRISTINE ,买入,3000普通股, $2.60

8-K - Current report Filed: 2012-02-17 AccNo: 0001193125-12-067641 Size: 21 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 8.01: Other Events 网页链接

SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-14 AccNo: 0000315066-12-002374 Size: 8 KB 网页链接

SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-09 AccNo: 0001086364-12-000435 Size: 13 KB 网页链接

10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2012-02-08 AccNo: 0001193125-12-046636 Size: 2 MB 网页链接

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-08 AccNo: 0000080255-12-000032 Size: 34 KB 网页链接

8-K - Current report Filed: 2012-02-07 AccNo: 0001193125-12-043737 Size: 104 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits 网页链接

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2012-02-07 AccNo: 0001041885-12-000013 Size: 9 KB 网页链接

美东时间 2012-02-07 03:30 Q1 2012 Avanir Pharmaceuticals Earnings Conference Call

DEF 14A - Other definitive proxy statements Filed: 2011-12-21 AccNo: 0001193125-11-348894 Size: 556 KB 网页链接

1 2 3 4 5 6 7 8 9 10